Friday, July 21, 2017
Project co-funded by the European Commission in the framework of the 2nd Health Programme
Enter Title Minimize

D.3. PROCESSING

  • D.3.1. ACTIVITIES
    • D.3.1.1. Reception
    • D.3.1.2. Access to the processing facilities
    • D.3.1.3. Processing
      • D.3.1.3.1.General
      • D.3.1.3.2. Processing methods
        • D.3.1.3.2.1. Processing of tissues
        • D.3.1.3.2.2. Decontamination of tissues
        • D.3.1.3.2.3. Sterilisation of tissues
        • D.3.1.3.2.4. Inactivation with regard to prions
    • D.3.1.4. Quality control
      • D.3.1.4.1. Microbiological control
        • D.3.1.4.1.1. General principle
        • D.3.1.4.1.2. Microbiological controls
    • D.3.1.5. Packaging and labelling
      • D.3.1.5.1. Primary packaging and labelling
    • D.3.1.6. Storage/ preservation
      • D.3.1.6.1. General
      • D.3.1.6.2. Methods of preservation and storage
        • D.3.1.6.2.1. Preservation and storage at 37ºC
        • D.3.1.6.2.2. Preservation and storage at +4°C
        • D.3.1.6.2.3. Cryopreservation at between ‐60°C and ‐80°C
        • D.3.1.6.2.4. Cryopreservation in liquid nitrogen
        • D.3.1.6.2.5. Glycerolisation with a high glycerol concentration
        • D.3.1.6.2.6. Lyophilisation and dehydration
        • D.3.1.6.2.7. Decelluralisation
        • D.3.1.6.2.8. Other preservation and storage procedures
      • D.3.1.6.3. Storage area
    • D.3.1.7. Documentation and release
      • D.3.1.7.1. General
      • D.3.1.7.2. Processing file contents
      • D.3.1.7.3. Availability for inspection
      • D.3.1.7.4. Traceability
Print  
A3f Engine ::Terms Of Use::Privacy Statement